Brompheniramine maleate 4 mg / pseudoephedrine HCl 60 mg Oral Capsule
RxNorm 1192477
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1192477 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: brompheniramine maleate 4 mg / pseudoephedrine HCl 60 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Brompheniramine maleate 4 mg / pseudoephedrine hydrochloride 60 mg Oral Capsule
(Atom ID: 12331699)
PSN
Prescribable Name (PSN):
Brompheniramine maleate 4 mg / pseudoephedrine HCl 60 mg Oral Capsule
(Atom ID: 6371187)
Patient Education
Brompheniramine
Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
Pseudoephedrine
Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.
[Learn More]
* Please review the disclaimer below.